ARDX
Price:
$5.69
Market Cap:
$1.41B
Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines. The company primarily focuses on addressing gastrointestinal (GI) and cardiorenal conditions, serving patients both domestically in the United States and across international markets. Its flagship product candidate is tenapanor. This drug has successfully completed Phase III clinical trials for treating irritable bowel syndrome with constipation (IBS-C) and is also currently in Phase III development to manage hyperphosphatemia (high serum phosphorus) in adult patients with chronic kidney disease (CKD) who are undergoing dialysis. Ardelyx is also advancing other ke...[Read more]
Industry
Biotechnology
IPO Date
2014-06-19
Stock Exchange
NASDAQ
Ticker
ARDX
According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.58B. This represents a change of 9.74% compared to the average of 1.44B of the last 4 quarters.
The mean historical Enterprise Value of Ardelyx, Inc. over the last ten years is 487.78M. The current 1.58B Enterprise Value has changed 32.35% with respect to the historical average. Over the past ten years (40 quarters), ARDX's Enterprise Value was at its highest in in the June 2024 quarter at 1.84B. The Enterprise Value was at its lowest in in the June 2016 quarter at -71161301.38.
Average
487.78M
Median
98.61M
Minimum
-4400586.25
Maximum
1.55B
Discovering the peaks and valleys of Ardelyx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 347.64%
Maximum Annual Enterprise Value = 1.55B
Minimum Annual Increase = -4299.24%
Minimum Annual Enterprise Value = -4400586.25
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.55B | 20.89% |
| 2024 | 1.28B | -8.12% |
| 2023 | 1.39B | 255.17% |
| 2022 | 392.59M | 347.64% |
| 2021 | 87.70M | -19.93% |
| 2020 | 109.53M | -4299.24% |
| 2019 | -2608235.92 | -40.73% |
| 2018 | -4400586.25 | -252.52% |
| 2017 | 2.89M | -95.75% |
| 2016 | 67.82M | -2155.02% |
The current Enterprise Value of Ardelyx, Inc. (ARDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.41B
5-year avg
940.92M
10-year avg
487.78M
Ardelyx, Inc.’s Enterprise Value is greater than Zymeworks Inc. (1.46B), greater than Maze Therapeutics, Inc. (1.19B), less than BioCryst Pharmaceuticals, Inc. (2.51B), less than Trevi Therapeutics, Inc. (2.00B), less than Spyre Therapeutics, Inc. (4.78B), greater than Intellia Therapeutics, Inc. (1.30B), less than Pharvaris N.V. (1.60B), greater than Wave Life Sciences Ltd. (600.52M), less than Stoke Therapeutics, Inc. (1.71B), greater than Upstream Bio, Inc. (236.35M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.46B | $1.68B | |
| 1.19B | $1.33B | |
| 2.51B | $1.83B | |
| 2.00B | $2.02B | |
| 4.78B | $4.88B | |
| 1.30B | $1.36B | |
| 1.60B | $2.15B | |
| 600.52M | $1.13B | |
| 1.71B | $1.86B | |
| 236.35M | $331.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ardelyx, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ardelyx, Inc. (ARDX)?
What is the 3-year average Enterprise Value for Ardelyx, Inc. (ARDX)?
What is the 5-year average Enterprise Value for Ardelyx, Inc. (ARDX)?
How does the current Enterprise Value for Ardelyx, Inc. (ARDX) compare to its historical average?